Stratos Wealth Partners’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PRPH
AWE
PCM
Stratos Wealth Partners's PRPH Position: Q1 2023 in Review
Stratos Wealth Partners sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 1,816 shares — an estimated $175K sold.
Stratos Wealth Partners first reported a position in PRPH in Q4 2022 and held it in 1 quarter. The position peaked at $175K in Q4 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.
- Stratos Wealth Partners reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
- Stratos Wealth Partners sold 1,816 ProPhase Labs shares in Q1 2023, an estimated $175K.
- Stratos Wealth Partners first reported a position in ProPhase Labs in Q4 2022 and held it in 1 quarter.
- Stratos Wealth Partners's ProPhase Labs position peaked at $175K in Q4 2022.
- 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.
Based on Stratos Wealth Partners's 13F filing for Q1 2023, filed 27 Apr 2023.